How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings. (Q51175993)

31 March 2018

title

How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings. (English)

1 reference

31 March 2018

1 reference

Paul G Farnham

1

1 reference

31 March 2018

Stephanie L Sansom

series ordinal

2

1 reference

31 March 2018

Angela B Hutchinson

series ordinal

3

1 reference

31 March 2018

publication date

12 January 2012

1 reference

31 March 2018

published in

Medical Decision Making

1 reference

31 March 2018

volume

32

1 reference

31 March 2018

issue

3

1 reference

31 March 2018

page(s)

459-469

1 reference

31 March 2018

Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Effect of early versus deferred antiretroviral therapy for HIV on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Peer referral for HIV case-finding among men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Comparing the costs of HIV screening strategies and technologies in health-care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Implementing an HIV and sexually transmitted disease screening program in an emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Scope of rapid HIV testing in urban U.S. hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Cost-effectiveness of a community-level HIV risk reduction intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

What is the price of life and why doesn't it increase at the rate of inflation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

A meta-analysis of utility estimates for HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Most positive HIV western blot tests do not diagnose new cases in New York City: implications for HIV testing programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Detection of acute HIV infections in high-risk patients in California.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Integrating routine HIV testing into a public health STD clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Cost of rapid HIV testing at 45 U.S. hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Outcomes and cost analysis of 3 operational models for rapid HIV testing services in an academic inner-city emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

Estimation of HIV incidence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11431609

21 January 2018

Identifiers

DOI

10.1177/0272989X11431609

1 reference

31 March 2018

1 reference

31 March 2018